TCTR20220722003尚未招募不适用
Clinical Characteristics and Outcomes of Relapsed or Refractory Hodgkin Lymphoma (rrHL) Treated with Brentuximab Vedotin (BV) in the Real World Clinical Practice in Thailand
适应症
试验速览
- 阶段
- 不适用
- 状态
- 尚未招募
- 入组人数
- 40
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- 18 Years 至 N/A (No limit)（—）
- 性别
- All
入选标准
- •1.Patients with RRHL
- •2.Age 18 years and above at diagnosis of rrHL
- •3.Received at least two .of BV prior to the date of site initiation and stopped or discontinued BV at the time of data extraction
排除标准
- •1.Patients who have participated in an interventional clinical trial at any stage of their treatment of rrHL
- •2.Patients who are on BV treatment at the time of chart data extraction
研究者
相似试验
进行中（未招募）
不适用
Treatment patterns and clinical outcomes of Recombinant Follicle Stimulating Hormone in South Korean patients who received Controlled Ovarian Hyper-stimulation: Results from a retrospective observational chart review studyKCT0004067Ferring pharmaceuticals Korea700
已完成
不适用
Prevalence, recovery patterns and risk factors of non-fatal outcome and costs after trauma; a prospective follow up study.NL-OMON41989Sint Elisabeth Ziekenhuis8,000
招募中
2 期
Treatment of patients with relapsed or refractory CD19+ lymphoid disease with T lymphocytes transduced by RV-SFG.CD19.CD28.4-BBzeta retroviral vector – A unicenter Phase I/II clinical trial [HD-CAR-1]2024-516832-82-00Universitaetsklinikum Heidelberg AöR63
已完成
不适用
ong-term outcome study of patients with refractory nephrotic syndrome after multicenter, double blind, randomized, placebo-controlled trial of rituximabrefractory nephrotic syndromeJPRN-UMIN000015220on-Profit Organization Japan Clincal Research Support Unit58
尚未招募
Unknown
Pattern of treatment in metastatic Breast Cancer PatientsCTRI/2023/05/052157Tata Memorial Centre